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Abstract
Background: The Lundehund is a highly specialized breed characterized by a unique flexibility of the joints and
polydactyly in all four limbs. The extremely small population size and high inbreeding has promoted a high
frequency of diseased dogs affected by the Lundehund syndrome (LS), a severe gastro-enteropathic disease.
Results: Comprehensive analysis of bead chip and whole-genome sequencing data for LS in the Lundehund
resulted in a genome-wide association signal on CFA 34 and LS-specific runs of homozygosity (ROH) in this region.
Filtering analysis for variants with predicted high or moderate effects revealed a missense mutation in LEPREL1 1.
2 Mb proximal to the region of the genome-wide association, which was shown to be significantly associated with
LS. LS-affected Lundehund harbored the mutant LEPREL1:g.139212C>G genotype A/A whereas all controls of other
breeds showed the C/C wild type.
In addition, ROH analysis for the Lundehund indicated a high enrichment of genes in potential signatures of
selection affecting protein activation and immunoregulatory processes like NOD1 potentially involved in LS breed
disposition.
Conclusions: Sequencing results for Lundehund specific traits reveal a potential causative mutation for LS in the
neuropeptide operating gene LEPREL1 and suggests it as a precursor of the inflammatory process. Analyses of ROH
regions give an insight into the genetic background of characteristic traits in the Lundehund that remain to be
elucidated in the future.
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Background
The Norwegian Lundehund represents a specific but
small group in the variety of dog breeds which have
evolved since domestication [1]. It stands out by excep-
tional characteristics like double dewclaws and extreme
flexibility in shoulder and neck, which represent traits
fixed in the Lundehund population [2]. In addition, the
Lundehund harbors a breed disposition for a syndrome
comprising particular features of protein-losing enteropathy
(PLE), intestinal lymphangiectasia, gastrointestinal disturb-
ance, inflammatory bowel disease and malabsorption
designated as Lundehund syndrome (LS) [3, 4]. Clinical
signs are diarrhea, vomiting, weight loss, edema and apathy
often accompanied with decreased concentrations of albu-
min and globulin in blood profile [2]. A similar condition
has been described in the Soft Coated Wheaten Terrier af-
fecting immune system, gut and kidney [5, 6]. It was sup-
posed that one or more genes involved in these complex
systems might be responsible for a breed disposition for
PLE. An increased occurrence of PLE could also be found
in Rottweilers and Yorkshire terriers [7–9]. In Basenji and
German Shepherd, hypoalbuminemia and hypoglobuline-
mia was found in dogs with severe lymphocytic-
plasmacytic enteritis characterized by excessive infiltrates of
mononuclear inflammatory cells [10, 11]. It was suggested
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that the inflammatory bowel disease in German Shepherd
was the result of a complex etiology with the involvement
of different variant effects similar to Crohn’s disease, the
chronic inflammatory bowel disease in human [12–15].
In the Lundehund, a signature of selection for LS was
suggested to be located on CFA 9 in the region of Cas-
pase Recruitment Domain Family, Member 9 (CARD9),
which is known to be associated with Crohn’s disease
and ulcerative colitis in human [16, 17]. In addition, ex-
tended haplotype homozygosity (EHH) tests suggested
further breed specific characteristics like polydactyly,
body size or flexibility of the joints as targets of specific
selection [17]. Genotyping the limb development mem-
brane protein 1 (LMBR1) mutation DC-2, which was
shown to be associated with preaxial polydactyly in west-
ern dogs, revealed the mutant genotype (A/A) in all
tested Lundehund [18, 19]. In general, the frequency of
long stretches of homozygous genotypes on basis of
bead chip data was shown to be high which was sug-
gested to be a result of an extremely low genetic vari-
ability in the Lundehund breed [1, 17, 20].
In this study whole-genome sequencing was per-
formed in two Lundehund pools comprising LS-affected
and LS-unaffected individuals. Sequence data were in-
vestigated for runs of homozygosity (ROHs) and variants
predicted to have high or moderate effects in order to
elucidate the genetic background of LS.
Results
Phenotype
Samples of six Lundehund dogs with typical characteris-
tics of a puffin hunter phenotype including an additional
toe and joint flexibility (Fig. 1) were chosen for whole-
genome sequencing in two pools. One pool enclosed three
healthy dogs whereas the other pool comprised three Lun-
dehund showing severe signs of gastroenteropathy known
as LS. In addition, 12 LS-affected Lundehund with clinical
signs and low blood protein parameters, 6 Lundehund
suspected to be LS-affected due to recurrent diarrhea and
vomiting and 12 Lundehund without clinical signs of LS
classified as LS-unaffected were available for further ana-
lysis. Characteristic clinical signs were diarrhea, vomiting,
weight loss and apathy (Fig. 2). The onset of first signs
varied widely from the age of 2.5 to 10.5 years (Additional
file 1). Some cases also showed ascites and edema in the
limbs. The results of blood screening revealed hypoalbu-
minemia in all analyzed cases, sometimes accompanied
with hypoglobulinemia, reduced levels of fructosamines
and vitamin B, hypo- or hypercalcemia, as well as in-
creased concentrations of serum folate and alanine
aminotransferase.
Fig. 1 Polydactyly in the Lundehund. Polydactyly with six toes at all
four limbs is a characteristic trait in the Lundehund
Fig. 2 Clinical picture of Lundehund syndrome (LS). A five year old
Lundehund with severe signs of LS is shown. Persistent diarrhea,
vomiting and ascites resulted in marked weight and hair loss. The
dog had to be euthanized due to poor prognosis and
unresponsive therapy
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Pedigree and association analysis
Inspection of the pedigree data of all Lundehund
under study revealed close relationships among
affected dogs (Additional file 2). In total 24 female
and 16 male LS-affected Lundehund were included in
this pedigree data. A complex segregation analysis re-
vealed a recessive major gene model as the most
likely mode of inheritance with the lowest −2 log-
likelihood at 52.68 (Additional file 3).
Genome-wide association analysis for LS in 17 LS-
affected and 8 LS-unaffected Lundehund showed a
highly significant peak on CFA 34 at 26,384,304-
27,498,705 bp (CanFam 2.0) corresponding to
23,373,982-24,488,983 bp in CanFam 3.1 assembly
(Fig. 3) in the region of fibroblast growth factor 12
(FGF12; ENSCAFG00000031187) and mab-21 domain
containing 2 (MB21D2; ENSCAFG00000014075). The
highest -log10P value (−log10P = 7.7) could be shown for
one SNP at 24,152,349 bp whereas further 30 SNPs in
the associated region reached -log10P-values of 5.6-5.9.
Expected versus observed -log10P-values (quantile-quan-
tile-plot) showed that inflation due to stratification ef-
fects had not increased -log10P-values. The distribution
of genotypes suggested a recessive effect as proposed by
segregation analysis.
Sequencing and variant detection
Whole-genome sequencing of two Lundehund pools
with three dogs each resulted in a mean coverage of
15.56X for Lundehund pool 1 (LS-affected) and 14.48X
Lundehund pool 2 (LS-unaffected). In total 10,584,482
SNPs and 3,223,567 insertions/deletions (INDEL) could
Fig. 3 Genome-wide association analysis (GWAS) for Lundehund syndrome (LS). a The Manhattan-plot of the -log10P-values shows a highly
significant peak on canine chromosome (CFA) 34 in the region of 23,373,982-24,488,983 bp (CanFam 3.0). b Observed versus expected -log10
P-values (Q-Q plot) reveal 31 SNPs with highly significant -log10P-values
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be detected for pool 1 as well as 10,530,165 SNPs and
3,207,163 INDEL for pool 2 in raw data after variant
calling. Stringent filters for read depth and quality of
each variant led to a set of 8,815,395 SNPs (pool 1) as
well as 8,799,793 SNPs (pool 2) for ROH analysis. For
these SNPs the mean heterozygosity per site was 0.11 in
both pools.
LS-specific ROH detection
A total of 1713 ROHs specific for LS-affected dogs were
detected. Three ROHs could be found directly in the re-
gion of association on CFA 34 at 23,223,356-
24,490,050 bp harboring the genes Coiled-Coil Domain
Containing 50 (CCDC50), FGF12 and MB21D2
(Additional file 4). In private ROHs analysis for homozy-
gous regions which could be exclusively found in LS-
affected as well as LS-unaffected Lundehund, 472 ROH
regions could be detected for pool 1 (LS-affected,
Additional file 5) and 408 ROH regions for pool 2 (LS-
unaffected, Additional file 6). The largest private ROH
region for pool 1 could also be found on CFA 15 in a
wider area of 7,812,609-13,628,020 bp including 51
genes.
Breed specific ROH
Consensus ROH detection was performed to identify po-
tential signatures of selection for unique breed specific
characteristics whose intense human selection might be
collaterally associated with the high incidence of LS in
the Lundehund population.
In total 660 Lundehund specific consensuses ROH re-
gions could be detected for 500-SNP windows (Add-
itional file 7). A notably high number of large stretches
of consecutive homozygous genotypes was found on
CFA 12 in the region of 32,968,627-49,633,816 bp and
CFA 7 in the region of 28,049,903-54,984,739 bp. These
regions harbored a large number of genes including
PRRX1 (paired related homeobox 1) and GREM2 (grem-
lin 2, DAN family BMP antagonist) on CFA 7. Further-
more, we detected a ROH region on CFA 14 at
42,891,687-43,618,177 bp harboring Nucleotide-Binding
Oligomerization Domain Containing 1 (NOD1). In con-
trast, no ROH region could be detected harboring the
candidate gene LMBR1 (limb development membrane
protein 1) for canine polydactyl mutations [19]. Further
genotyping of the intronic LMBR1 SNP DC-2 revealed
the mutant DC-2 allele homozygous in all analyzed Lun-
dehund but also in the Norwegian Buhund, Bernese
Mountain Dogs, Briard and Irish Wolfhound (Additional
file 8).
Variants in ROH regions
Detection of SNPs or INDEL predicted to have high or
moderate effects in ROH regions was performed to
identify LS-specific or Lundehund-specific variants. No
variant with predicted high or moderate effects could be
detected within FGF12 and MB21D2 located in the re-
gion of ROHs found in the LS-affected (pool 1) which
matched the region of genome-wide association. In total
2036 intron variants with a homozygous mutant geno-
type in LS-affected Lundehund, one 3′UTR and 13 5′
UTR variants could be found in FGF12 with predicted
low or modifier effects only. In MB21D2 no LS-
associated variant could be detected.
Analysis of private LS-specific ROH regions resulted
in one variant with a homozygous mutant genotype in
LS-affected Lundehund, a heterozygous genotype in LS-
unaffected Lundehund and a wildtype genotype in con-
trols. This missense variant COL28A1:g.159951T>A on
ECA14 was predicted to be deleterious (SIFT) as well as
probably damaging (PolyPhen).
In ROH regions detected in all Lundehund (pool 1
and 2) seven variants with predicted tolerated or dele-
terious (low confidence) effects could be found. The
candidate genes PRRX1 and GREM2 did not harbor vari-
ants with predicted high or moderate effects. Neverthe-
less, ten intronic variants could be detected in PRRX1
with mutant homozygous genotypes exclusively found in
the Lundehund pools.
Functional annotation of ROH regions
Functional gene classification of human orthologues de-
tected in ROH regions showed a particularly high in-
volvement in biological processes affecting cellular
processes (GO:0009987), localization (GO:0051179), re-
sponse to stimulus (GO:0050896) and metabolic pro-
cesses (GO:0008152) in all data sets (Additional file 9).
PANTHER overrepresentation test in ROH regions in
LS-affected Lundehund revealed an enrichment of
genes involved in cellular process (GO:0009987,
GO:0006464), metabolic process (GO:0008152,
GO:0019538, GO:0044238, GO:0019219) and tran-
scription (GO:0006351). Private ROHs detected in LS-
affected dogs revealed a >5 fold enrichment of genes
known to play a role in negative regulation of com-
plement activation (GO:0045916), protein activation
cascade (GO:2000258), humoral immune response
(GO:0002921) and also in the perception of taste
(GO:0001580, GO:0050913, GO:0050912, GO:0050909).
In consensus Lundehund ROH regions genes affecting
single-organism (GO:0044763) as well as cellular
(GO:0009987) and biological (GO:0008150) processes
were predicted to be overrepresented (Table 1).
Filtering for mutations with predicted high or moderate
effects
Specific filtering for variants with predicted high or mod-
erate effects in the region of genome-wide association for
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Table 1 Statistical overrepresentation test for biological processes. All human orthologues derived from ROH detection were analyzed for an enrichment of genes involved in







































11415 ─ ─ ─ ─ ─ ─ 480.42 1.03E-06
Single-organism process
(GO:0044699)
12755 ─ ─ ─ ─ ─ ─ 536.82 5.36E-06
Cellular process (GO:0009987) 14147 1714.55 3.37E-05 ─ ─ ─ ─ 595.41 4.70E-07
Biological process
(GO:0008150)
16542 ─ ─ ─ ─ ─ ─ 696.2 1.02E-04
Generation of neurons
(GO:0048699)
1551 ─ ─ ─ ─ 61.18 1.61E-02 ─ ─




5188 ─ ─ ─ ─ 204.64 1.47E-02 ─ ─
Cellular protein modification
process (GO:0006464)
1317 336.62 1.15E-03 ─ ─ ─ ─ ─ ─
Protein metabolic process
(GO:0019538)
2692 688.07 2.95E-04 ─ ─ ─ ─ ─ ─
Metabolic process
(GO:0008152)
8247 2107.91 7.09E-04 ─ ─ ─ ─ ─ ─
Primary metabolic process
(GO:0044238)
6825 1744.45 1.39E-02 ─ ─ ─ ─ ─ ─
Transcription, DNA-
dependent (GO:0006351)


















Table 2 Filtered variants from whole-genome analysis. Variants with predicted high or moderate effects and a homozygous mutant genotype exclusively found in the
LS-affected pool as well as a heterozygous or homozygous wild-type genotype in the LS-unaffected pool are shown. All five reference dogs of four different breeds do not show
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1 111903572 A>G T>A missense
variant







benign (0.00)/ benign (0.310)/
possibly damaging (0.659)/ possibly
damaging (0.605)/ benign (0.250)
3 56483857 G>T P>T missense
variant
1/1 0/1 0/0 IL16 (ENSCAFT00000021964) tolerated
(0.59)
benign (0.310)
3 62265062 A>T F>I missense
variant





5 16233038 G>T L>M missense
variant
1/1 0/1 0/0 CEP164 (ENSCAFT00000020686) deleterious
(0.02)
probably damaging (0.996)
6 67204999 C>T R>Q non coding
transcript
variant
1/1 0/1 0/0 ENSCAFG00000005648 (novel gene;
ENSCAFT00000009086)
- -






1/1 0/1 0/0 ENSCAFG00000005648 (novel gene;
ENSCAFT00000009086)
- -






1/1 0/1 0/0 ENSCAFG00000005648 (novel gene;
ENSCAFT00000009086)
- -
6 67205959 A>G L>P non coding
transcript
variant
1/1 0/1 0/0 ENSCAFG00000005648 (novel gene;
ENSCAFT00000009086)
- -
6 67205966 T>G T>P non coding
transcript
variant
1/1 0/1 0/0 ENSCAFG00000005648 (novel gene;
ENSCAFT00000009086)
- -
7 2590167 G>A S>N missense
variant
1/1 0/1 0/0 KIF14 (ENSCAFT00000017720) tolerated
(0.21)
benign (0.002)
7 4169250 A>T F>Y missense
variant






8 22616300 C>T P>L missense
variant





benign (0.009/ 0.009/ 0.004 )
8 47544408 G>A G>R missense
variant
















Table 2 Filtered variants from whole-genome analysis. Variants with predicted high or moderate effects and a homozygous mutant genotype exclusively found in the
LS-affected pool as well as a heterozygous or homozygous wild-type genotype in the LS-unaffected pool are shown. All five reference dogs of four different breeds do not show
the mutant genotype. Potential functional effects of these variants were predicted using SIFT and PolyPhen (Continued)
8 73685892 C>G Q>H missense
variant





8 73685923 C>G W>S missense
variant





8 73685927 T>G S>R missense
variant





9 37739213 C>T R>W missense
variant





9 51227945 T>C H>R missense
variant





10 36330685 C>T A>V missense
variant
1/1 0/1 0/0 FAM32A (ENSCAFT00000003279) tolerated
(0.16)
benign (0.328)
11 67454670 A>C S>R missense
variant









1/1 0/1 0/0 ENSCAFG00000030790 (novel gene;
ENSCAFT00000045206)
- -
12 52354031 A>G F>S missense
variant





12 52354041 G>A L>F missense
variant





14 16187782 T>G I>M missense
variant
1/1 0/1 0/0 CFAP69 (ENSCAFT00000002973) tolerated
(0.23)
possibly damaging (0.648)
14 22993351 A>T C>S missense
variant
1/1 0/1 0/0 COL28A1 (ENSCAFT00000044570) deleterious
(0)
probably damaging (1.000)
18 39577830 C>T A>V missense
variant
1/1 0/1 0/0 ENSCAFG00000030998 (novel gene;
ENSCAFT00000047197)





1/1 0/1 0/0 KDM4B (ENSCAFT00000030040) tolerated
(0.7)
possibly damaging (0.728)
27 2322565 C>T R>C missense
variant
1/1 0/1 0/0 KRT3 (ENSCAFT00000011634) deleterious
(0.03)
possibly damaging (0.942)
28 31706107 A>C N>T missense
variant





32 21555092 C>T D>N missense
variant
1/1 0/1 0/0 TRMT10A (ENSCAFT00000016732) tolerated
(0.31)
probably damaging (0.997)
34 22046092 C>G E>Q missense
variant


























LS revealed no variant directly in this region but one mis-
sense mutation 1.2 Mb proximal to the peak of association
in the candidate gene LEPREL1 (Table 2). It was predicted
to result in a substitution glutamic acid to glutamine.
In addition, specific filtering was done for further can-
didate variants which could potentially be involved in
disease development of LS and might have been missed
in the specified ROH detection windows or association
analysis. We extracted genetic variants putatively associ-
ated with LS with predicted high or moderate effects
which showed a homozygous mutant genotype only in
LS-affected and a heterozygous mutant or wildtype
genotype in LS-unaffected dogs. In total 32 SNPs and
one INDEL resulted from filtering analysis.
Based on these results we chose the missense
mutation LEPREL1:g.139212C>G near the region of
genome-wide association and further six single nu-
cleotide variants (SNV) in other genomic regions
which were predicted to be deleterious (SIFT [21]) as
well as possibly or probably damaging (PolyPhen [22])
for validation in all Lundehund samples and across
several dog breeds. Three of these SNVs located in
regions of an extreme high density of mutations,
probably a result of inaccurate gene annotation, were
assumed to be false positive results and therefore
omitted from analysis. Genotyping of the remaining
four non-synonymous SNVs in the region of the can-
didate genes leprecan-like 1 (LEPREL1), centrosomal
protein 164 kDa (CEP164), collagen, type XXVII,
alpha 1 (COL28A1) and keratin 3 (KRT3) in 36
Lundehund revealed a significant association of
CEP164:g.57380G>T and LEPREL1:g.139212C>G with
LS (Table 3).
Further genotyping of 186 dogs of 17 breeds with no
signs of gastroenteropathic disease showed only
LEPREL1:g.139212C>G and COL28A1:g.159951T>A to
be breed specific mutations for the Lundehund
(Additional file 10) and revealed no significant P-value
for COL28A1:g.159951T>A, but a significant P-value of
1.503E-29 for LEPREL1:g.139212C>G (Table 4). A closer
look at the LS-phenotypes showed that all 17 LS-
affected Lundhund harbored the homozygous mutant
LEPREL1:g.139212C>G genotype whereas three of the
six dogs which were estimated to be LS-suspicious due
to clinical signs, did not show the homozygous mutant
genotype.
Candidate gene sequencing
Sequence analysis of LEPREL1 cDNA confirmed the
missense mutation in exon 13 in LS-affected Lundehund
dogs. No further SNVs could be found in LEPREL1 to be
associated with LS (Additional file 11). Sequencing the
complementary DNA (cDNA) of MB21D2 in an affected
Lundehund and a reference German Shepherd dog re-
vealed three mutations. Nevertheless, none of these mu-
tations could be exclusively found in the Lundehund.
The predicted gene FGF12 cDNA could not be amplified
at all.
Table 3 Genotypic distribution of candidate SNPs for LS in Lundehund dogs. Chi-square test results are shown for the four
candidate SNPs chosen from filtering analysis for mutations predicted to have high or moderate effects. Genotypes are assigned
to Lundehund without signs of LS (0), LS-affected Lundehund (1) and LS-suspicious dogs (1 susp.) due to clinical signs






























0 1 (2.78) 7 (19.44) 7 (19.44)
1 0 (0.00) 0 (0.00) 15 (41.70)
1 (susp.) 1 (2.78) 2 (5.56) 3 (8.34)






0 4 (11.43) 6 (17.14) 5 (14.29)
1 0 (0.00) 7 (19.46) 7 (19.46)
1 (susp.) 0 (0.00) 2 (5.56) 4 (11.12)






0 3 (8.57) 7 (20.00) 5 (14.29)
1 2 (5.72) 8 (22.80) 4 (11.44)
1 (susp.) 1 (2.86) 4 (11.44) 1 (2.86)






0 3 (8.33) 8 (22.22) 4 (11.11)
1 3 (8.33) 4 (11.12) 8 (22.22)
1 (susp.) 0 (0.00) 2 (5.56) 4 (11.12)
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Discussion
Whole-genome sequencing analysis in two pools of Lun-
dehund dogs revealed a candidate gene for LS-
disposition and gave evidence for potential LS-related
signatures of selection. The genome-wide association
analysis resulted in a significant peak on CFA 34 which
could also be shown to be located in a ROH region for
LS-affected dogs. Screening of whole-genome data did
not reveal any LS-associated mutations with predicted
high impacts on protein function but the missense mu-
tation LEPREL1:g.139212C>G 1.2 Mb proximal of the
region of significant genome-wide association. We as-
sume that the shift of the peak of LS-association and
LS-associated ROH region might be a result of the low
bead chip marker density that could be found in the re-
gion of LEPREL1. Furthermore, it could be shown that
the detection of ROHs is strongly dependent on the win-
dow size and marker density [23] so that not all homo-
zygous stretches can be detected in 500-SNP windows.
We assume that smaller windows could probably have
enabled the detection of a ROH region comprising
LEPREL1 but might have increased the number of false
positive results, too. According to the suggested reces-
sive mode of inheritance the missense mutation
LEPREL1:g.139212C>G could be shown to be homozy-
gous in all analyzed dogs in NGS data. LS-affected dogs
showed the mutant genotype G/G whereas LS-
unaffected controls of other breeds did harbor the
homozygous wild type C/C. In addition, seven Lunde-
hund with no clinical signs for LS also showed the mu-
tant genotype G/G. Due to the variable onset of the
disease it can be proposed that these dogs will develop
signs of the disease later in their life. We suggest this
SNV as a potential causative mutation for a genetic dis-
position for LS.
LEPREL1 was shown to be expressed in a subpopu-
lation of neuroendocrine cells of the intestinal mu-
cosa and suggested to be important for processing
and secretion of neuropeptides [24]. It was proposed
that the enteric nervous system could trigger the oc-
currence of inflammatory bowel disease through
neuropeptide secretion [25]. Neuropeptides were pro-
posed to play a key role in inflammatory bowel dis-
eases [25, 26]. Blockades for these molecules were
considered for therapeutic approaches. We assume
mutant LEPREL1 might be an essential precursor for
LS in the Lundehund. Lundehund without clinical
signs for LS who harbor this mutant RNA could pos-
sibly be subclinically affected or fall ill later in their
life by specific trigger mechanisms. It was shown that
not a few Lundehund who appeared healthy often
had abnormal findings in histopathologic examina-
tions [2]. The onset of the disease could be influ-
enced by external factors triggering phenotypic
expression. In the Soft Coated Wheaten Terrier it
was proposed that food allergies could play a role in
the development of PLE [5, 27]. In addition to exter-
nal factors, further genes might be involved in trig-
gering LS as well as influence the severity of
symptoms. In human Crohn’s disease various muta-
tions have been shown to be associated with disease
development in different populations [13, 28–33]. It
was suggested that complex regulatory processes
driven by various genes could affect the extent of de-
fects and result in different severities.
We assume that further genes might be involved in
LS-development and could potentially be related to tar-
gets of selection for breed specific traits. This could
probably explain the high incidence of LS in the popula-
tion. In general, ROH analysis for the Lundehund
showed a high frequency of long stretches of homozy-
gous genotypes as expected from the extremely low gen-
etic variability of this breed [1]. A high enrichment of
genes in these ROH regions affecting protein activation,
complement activation and humoral immune response
suggested that protein-protein interactions and immu-
noregulatory processes might play an important role in
the development of LS in the Lundehund as it was previ-
ously proposed for PLE in the Soft Coated Wheaten
Terrier [5].
Variants in the candidate gene NOD1 (CARD4), which
could be found to harbor a Lundehund specific ROH re-
gion, have been shown to be highly susceptible to in-
flammatory bowel disease [30]. It was proposed that
NOD1 plays an important role in colonic epithelial pro-
tection against intracellular organisms similar to mucin
genes. In Lundehund affected with atrophic gastritis an
abnormal presence of mucous neck cells could be
Table 4 Chi-square test for Lundehund dogs and seventeen different breeds. Other breeds are used as controls for Lundehund-specific
LS. The test results are shown for the four candidate SNPs chosen from filtering analysis for mutations predicted to have high or
moderate effects
CFA Gene Polymorphism Chi-Square genotype (Probability) Chi-Square allele (Probability) Chi-Square trend (Probability)
34 LEPREL1 LEPREL1:g.139212C>G 132.735 (P = 1.503E-29) 238.686 (P = 7.607E-54) 130.861 (P = 2.655E-30)
5 CEP164 CEP164:g.57380G>T 83.884 (P = 6.092E-19) 120.165 (P = 5.822E-28) 83.716 (P = 5.712E-20)
14 COL28A1 COL28A1:g.159951T>A 101.034 (P = 1.150E-22) 116.566 (P = 3.573E-27) 79.531 (P = 4.748E-19)
27 KRT3 KRT3:g.2584C>T 3.379 (P = 0.184) 2.483 (P = 0.115) 2.146 (P = 0.173)
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detected in the gastric mucosa [34]. We suppose that
this gene, potentially under targeted selection in the
Lundehund, might predispose this breed in general for
gastrointestinal problems.
Further potential signatures of selection could be de-
tected in the region of genes that might be involved in
breed specific conformational traits like joint flexibility
or polydactyly. According to Lundehund breed standard,
the Lundehund was reported to have at least six toes at
fore and hind limps [2, 18, 20]. Mapping analysis for
hind limp specific canine preaxial polydactyly revealed a
potentially causative mutation in LMBR1 (DC-2) in
western dog breeds [19]. The homozygous mutant DC-2
genotype was also found in the Lundehund [18] and
could be confirmed in all 36 Lundehund in our study.
Nevertheless, it was still unclear if this mutation could
explain the characteristic phenotype in the Lundehund
showing polydactyly at both fore and hind limps in con-
trast to the usually unchanged forelimb in dogs with
polydactyly [19]. We found evidence in Lundehund con-
sensus ROH regions for potential modifier genes that
might play a role in limb development. GREM2 was
shown to be expressed in osteoblasts during in vivo ske-
letogenesis and involved in the regulation of bone for-
mation genes [35, 36]. It was suggested that GREM2 was
bidirectionally regulated by bone morphogenetic protein
2 (BMP2) together with GREM1, a gene which was
shown to be expressed along with sonic hedgehog (SHH)
and play an important role in limb bud development
[36, 37]. A similar effect was suggested for PRRX1
(PRX1). Loss-of-function mutant PRRX1/PRRX2 mice
resulted in shortened zeugopods of the forelimbs and
hindlimbs as well as postaxial polydactyly in the forelimb
[38]. EHH analysis in the Lundehund revealed PRRX2 in
long-range homozygous haplotypes suggesting this gene
as a candidate for Lundehund-polydactyly [17]. We as-
sume that these genes under potential targeted selection
could explain the specific phenotypic characteristic for a
four-limb polydactyly in the Lundehund.
Conclusions
In conclusion, our study of whole-genome sequencing
data of Lundehund dogs suggests LEPREL1:g.139212C>G
as a potential causative mutation for LS as well as NOD1
as a potential precursor gene which might play a role in
LS breed predisposition. In addition, we identified poten-
tial signatures of selection for characteristic breed specific
traits whose targeted selection might have increased gen-
etic risk factors for disease development.
The results of our analysis represent a significant step
to identify the genetic background of Lundehund spe-
cific traits which still remain to be further investigated




Genomic DNA was obtained from blood samples of 36
Lundehund and 186 dogs of different dog breeds includ-
ing Norwegian Buhund and Norrbottenspets using a
standard saline precipitation method [39]. Lundehund
specific phenotypes and affection-status were obtained
on basis a questionnaire filled in by dog owners and vet-
erinarians. Information about the pedigree, date of birth,
date of euthanasia and signs of LS like diarrhea, vomit-
ing and cachexia was recorded using this form. Further
blood parameters were added from clinically examined
dogs.
Association analysis
In total 25 Lundehund (17 LS-affected and 8 LS-
unaffected) were genotyped on the canine Illumina high
density bead chip (Illumina) according to manufacturer’s
protocols. Quality of genotyping data was controlled
using a minor allele frequency (MAF) >0.05 and a geno-
typing rate per SNP >0.90. Filtering resulted in 93,882
SNPs with a mean genotyping rate of 99 %. Genome-
wide association analysis was run using TASSEL version
3.0 [40]. Generalized linear model (GLM) with sex, in-
breeding coefficients and three PCA’s was run to test the
model. Quantile-quantile (Q-Q) plots for observed ver-
sus expected -log10P-values were calculated to control
for population stratification using SAS/Genetics.
Pedigree analysis
Pedigree analysis was performed using regressive logistic
models and the procedure SEGREG of S.A.G.E. (Statis-
tical Analysis for Genetic Epidemiology, Release 6.3:
http://darwin.cwru.edu, 2012) to test the most likely
mode of inheritance for LS. We tested the hypothesis for
the μ model without any genetic component, monogenic
inheritance, polygenic inheritance and mixed major gene
inheritance with a polygenic component and an inde-
pendently segregating major gene locus with two alleles.
Whole-genome sequencing
Whole genome sequencing of Lundehund samples was
performed on the Illumina MiSeq (Illumina, San Diego,
CA) in paired-end mode. Libraries were prepared for
one DNA-pool of three LS-affected Lundehund and for
one DNA-pool of three LS-unaffected Lundehund using
the Illumina Nextera DNA Sample Prep Kit according to
standard protocols. We performed four runs for each
pool with v2 Reagent Kits (Illumina) on a single lane
flow cell (2 × 250 bp reads). Fastq-files were quality con-
trolled using fastqc 0.11.3 [41]. Mapping to the reference
genome CanFam 3.1.78 was performed using BWA
0.7.12 [42] followed by conversion into binary format
using SAMtools 1.2 [43] and PCR duplicate marking
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using Picard tools (http://broadinstitute.github.io/picard/,
version 1.130). Furthermore, we locally realigned reads
and performed quality score recalibration and SNP calling
using GATK [44]. In addition to the Lundehund fastq
files we added five whole-genome sequences of one
Korean Jindo Dog (DRR001566), one Afghan Hound
(SRR1061643), two German Shepherd dogs (SRR1130247
and SRR1124304) and one Border Collie (SRR654728)
from Sequence Read Archive (NCBI) to analysis. Quality
of the data was controlled filtering variants for a read
depth >2 and <1000 and quality values >20 (qual). Vari-
ant effects were predicted using the genetic variant an-
notation and effect prediction toolbox SNPEff version
4.1 b (2015-02-13) [45].
ROH detection
ROHs were detected using a stringently quality-controlled
autosomal dataset of 8,585,517 SNPs showing a minimum
read depth of 3, a maximum read depth of 60, a minimum
mean read depth of 12 and minor allele frequency 0.01 for
all samples. Sliding windows of 500 SNPs were chosen for
ROH analysis. Homozygous regions of >150 kb were de-
tected as ROHs using PLINK, version 1.07 (http://
pngu.mgh.harvard.edu/purcell/plink/). Based on the gen-
ome size covered with SNPs divided by the number of
SNPs we estimated the minimum distance of SNPs as 0.3.
A maximum of three SNPs with missing genotypes and
three heterozygous SNPs were admitted in each window.
ROHs were filtered for LS-specific and Lundehund spe-
cific ROH regions based on hom.summary data outputs
from ROH analysis for each dog using SAS/Genetics, ver-
sion 9.4 (Statistical Analysis System, Cary, NC). The
homozygosity information of each SNP (1 = homozygosity,
0 = no homozygosity) was detected and compared to the
other individuals in order to identify overlapping and pri-
vate regions, the number of SNPs and length of the re-
gions. These specific ROH regions were searched for
variants predicted to have high or moderate effects
(SNPEff).
Functional annotation
Chromosomal positions of ROH regions were merged with
Ensembl gene predictions (ensGene) using Galaxy intersec-
tion tool (https://usegalaxy.org/) [46, 47]. The obtained
gene lists were converted into human orthologous genes
using g:Profiler [48, 49] and tested for statistical overrepre-
sentation in biological processes (PANTHER Overrepresen-
tation Test; release 20150430, version 10.0) [50].
Filtering analysis
Analysis of sequencing data was performed identifying
variants with SNPEff-predicted high or moderate effects
with a homozygous mutant genotype in the LS-affected
pool, a heterozygous or homozygous wild-type genotype
in LS-unaffected pool and a homozygous wild-type
genotype in the other five dogs of different breeds using
SAS/Genetics 9.4. Variants flagged with warnings about
possible annotation accuracy problems were omitted
from analysis. The candidate SNP in LEPREL1 and fur-
ther 23 SNPs were investigated for functional effects
using the Variant Effect Predictor [51] for SIFT [21] pre-
dictions and PolyPhen [22]. Regions of SNPs that were
predicted to be deleterious (SIFT) and possibly or prob-
ably damaging (PolyPhen) had been further investigated
for a high density of mutations around the candidate
SNP that could reference to annotation problems.
Genotyping
Genotyping of the candidate SNPs LEPREL1:g.139212C>G,
KRT3:g.2584C>T as well as the polydactyly-associated poly-
morphism in LMBR1 (DC-2) was performed using
restriction fragment length polymorphisms according to
standard protocols [52]. DC-2 primers were obtained from
previous study [18]. In addition the missense variants
CEP164:g.57380G>T and COL28A1:g.159951T>A were val-
idated using Kompetitive Allele Specific PCR (KASP) geno-
typing assays (LGC, Middlesex, UK) [53]. After the KASP
standard thermal cycling touchdown protocol was run on a
thermocycler TProfessional 96 (Biometra, Göttingen,
Germany) using an annealing temperature of 61 °C
(Additional file 12), allelic discrimination was performed on
the ABI7300 sequence detection system (Applied Biosys-
tems, Waltham, Massachusetts, USA).
Sequencing of candidate genes
Sanger sequencing of the cDNA of MB21D2 and
LEPREL1 was performed in one LS-affected Lundehund
and one Great Dane as control dog. RNA was obtained
from hair roots in stabilized RNALater reagent (Quiagen,
Maryland, USA), transcribed into cDNA and used for
PCR amplification according to a standardized protocol
[54] (Additional file 13). Alignment and variant detection
was performed using the analysis software Sequencher 4.8
(Genes Codes, Ann Arbor, MI, USA). Despite the use of
Q-solution (Quiagen) as enhancer reagent and Gradient
PCR for optimizing reaction conditions, the coding region
of FGF12 could not be amplified from these hair root
samples at all.
Additional files
Additional file 1: Clinical data of 21 Lundehund with signs of LS. Blood
parameters of total protein (TP), albumin (ALB), globulin (GLOB),
fructosamine (F), alkaline phosphatase (ALKP), alanine aminotransferase
(ALT), vitamin B12 (B12) and folic acid (FA) are shown. (DOCX 18 kb)
Additional file 2: Pedigree of LS-affected Lundehund. In total, samples
of twenty-one LS-affected and fifteen LS-unaffected Lundehund were
available for analysis. A common pedigree for all these dogs shows a
close relationship in-between all Lundehund dogs. Whole genome
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sequencing was performed in three affected and three LS-unaffected
dogs (numbers in boxes) whereas genotyping on the Illumina high
density bead chip was done for seventeen LS-affected and eight LS-
unaffected Lundehund (numbers S1-S25). (TIF 2248 kb)
Additional file 3: Results of complex segregation analysis using
regressive logistic models for LS in the Lundehund. (DOCX 12 kb)
Additional file 4: Runs of homozygosity for LS-affected Lundehund in
500-SNP windows. The chromosomal position of ROH regions, number of
SNPs in these regions (n), size in base pairs (size_bp), canine genes (gene)
and human orthologues (human gene) are shown. (XLSX 319 kb)
Additional file 5: Private runs of homozygosity for LS-affected Lundehund
in 500-SNP windows. The chromosomal position of ROH regions, number of
SNPs in these regions (n), size in base pairs (size_bp), canine genes (gene)
and human orthologues (human gene) are shown. (XLSX 60 kb)
Additional file 6: Private runs of homozygosity for LS-unaffected
Lundehund in 500-SNP windows. The chromosomal position of ROH
regions, number of SNPs in these regions (n), size in base pairs (size_bp),
canine genes (gene) and human orthologues (human gene) are shown.
(XLSX 65 kb)
Additional file 7: Runs of homozygosity for Lundehund specific regions
in 500-SNP windows. The chromosomal position of ROH regions, number
of SNPs in these regions (n), size in base pairs (size_bp), canine genes
(gene) and human orthologues (human gene) are shown. (XLSX 88 kb)
Additional file 8: Genotyping results for DC-2 mutation. The intronic
LMBR1 SNP which is known to be associated with polydactyly (Park,
2008) was genotyped for all Lundehund and further 13 different dog
breeds. (DOCX 13 kb)
Additional file 9: Functional annotations for runs of homozygosity
(ROH) in the Lundehund. PANTHER gene list analysis shows the
proportion of gene hits against total number of process hits for genes
detected in Lundehund consensus as well as LS-specific and private ROHs
for LS-affected and LS-unaffected dogs. Detected ROHs were investigated
for genes and their involvement in specific biologic processes.
(DOCX 16 kb)
Additional file 10: Allele frequencies of candidate SNPs. In total 186
samples of 17 breeds were genotyped for the LS-candidate SNPs
LEPREL1:g.139212C>G, KRT3:g.2584C>T, COL28A1:g.159951T>A and
CEP164:g.57380G>T. In KRT3:g.2584C>T and CEP164:g.57380G>T the
mutant allele could be detected in other breeds whereas
LEPREL1:g.139212C>G and COL28A1:g.159951T>A could not be found in
any other dog breed than the Lundehund. (DOCX 14 kb)
Additional file 11: Mutations detected in sequencing analysis of
MB21D2 and LEPREL1. None of the synonymous as well as 3 prime UTR
mutations could be shown to be exclusively found in the Lundehund
except LEPREL1:c.1849C>G. (DOCX 13 kb)
Additional file 12: Primer sequences used for genotyping of candidate
SNPs. The two variants located in KRT3 and LEPREL1 were genotyped by
the use of restriction fragment length polymorphisms (RFLP). KASP-primers
were used for genotyping CEP164 and COL28A1 variants. Primer pairs,
amplicon size (AS) in base pairs (bp), annealing (AT), restriction enzyme and
incubation temperature (IT) are shown. The polymorphism DC-2 in LMBR1
was detected using primer pairs previously published (Kropatsch, 2015).
(DOCX 14 kb)
Additional file 13: Sequences of primers used for the investigation of
MB21D2 and LEPREL1 complementary DNA. The gene region, product
sizes in base pairs (bp) and annealing temperatures are shown.
(DOCX 13 kb)
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